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In advanced radiotherapy, treatment of the tumor with
high-intensity modulated fields is balanced with normal
tissue sparing. However, the non-target dose delivered to
surrounding healthy tissue within the irradiated volume is
a potential cause for concern. Whether the effects observed
are caused after exposure to out-of-field radiation or
bystander effects through neighboring irradiated cells is
not fully understood. The goal of this study was to
determine the effect of exposure to out-of-field radiation
in lymphocyte cell lines and primary blood cells. The role
of cellular radiosensitivity in altering bystander responses
in out-of-field exposed cells was also investigated. Target
cells were positioned in a phantom in the center of the
radiation field (in-field dose) and exposed to 2 Gy
irradiation. Lymphocyte cell lines (C1, AT3ABR, Jurkat,
THP-1, AT2Bi and AT3Bi) and peripheral blood were
placed 1 cm away from the radiation field edge (out-of-
field dose) and received an average dose of 10.8 6 4.2 cGy.
Double-stranded DNA damage, cell growth and gene
expression were measured in the out-of-field cells. Radio-
sensitive AT3ABR and primary blood cells demonstrated
the largest increase in c-H2AX foci after irradiation.
Exposure of normal cells to bystander factors from
irradiated radiosensitive cell lines also increased DNA
damage. Expression of IL-1, IL-6, TNFa and TGFb after
addition of bystander factors from radiosensitive cells
showed differential effects in normally responding cells,
with some evidence of an adaptive response observed.
Exposure to out-of-field radiation induces DNA damage
and reduces growth in radiosensitive cells. Bystander
factors produced by directly irradiated cells in combina-
tion with out-of-field exposure may upregulate pro- and
anti-inflammatory genes in responding cells of different
radiosensitivities, with the potential of affecting the tumor
microenvironment. A greater understanding of the radio-
biological response in normal cells outside the primary
treatment field would assist in radiation treatment
planning and in reducing early and late toxicities.  2019
by Radiation Research Society
INTRODUCTION
Advances in radiotherapy have increased the treatment
efficacy and survival rates of several prevalent cancers,
however, many patients experience some level of early or
late radiotherapy-related toxicity. These effects range from
mild to debilitating, and can severely affect quality of life of
the patient. Radiation treatments balance the delivery of a
uniform dose to the tumor, resulting in DNA damage and
cell death, while sparing the surrounding healthy structures.
However, normal tissue within the irradiated volume
affected by a low-dose bath has increasingly become a
potential cause for concern [reviewed in (1)]. Radiation-
related toxicities are initiated through a combination of
factors, including normal cell damage, cellular radiosensi-
tivity and induction of an immune response (2–6). It is
imperative that we continue to elucidate these factors and
their relationship to the radiation dose and modality in an
effort to reduce toxicities.
Normal cells can be affected in a non-targeted manner
through scattered and transmitted radiation (out-of-field
effects), and through cellular crosstalk, in part through
soluble mediators produced by adjacent directly irradiated
cells (the bystander effect). Recently, the bystander effect
has been studied using clinical radiotherapy protocols to
examine the effects on normal tissue during treatment.
McGarry et al. used modulated fields and flask shielding
during irradiation of AGO-1522b fibroblasts and DU145
prostate tumor cells to demonstrate out-of-field cell death
(7). Previously published work from our group showed
increased DNA damage and reduced colony volume in
PNT1A normal prostate cells placed 1 cm away from the
radiation field edge (out-of-field) (8).
The tumor microenvironment and its surrounding healthy
tissue comprise a complex network of blood vessels, tumor
and inflammatory cells, cytokines, chemokines and reactive
1 Address for correspondence: Radiation and Environmental
Science Centre, FOCAS Institute, Technological University Dublin,
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oxygen species (ROS) (9–11). Previously published studies
have documented the involvement of factors including
ROS, TGFb, TNFa and IL-6 in the bystander effect,
induced by low- and high-dose exposure to radiation (12–
17). Alterations in these signaling pathways due to radiation
or other treatments may affect the overall efficacy of
radiation treatment. This could occur through induction of
regulatory cells that inhibit anti-tumor responses, and dose-
limiting toxicities arising from chronic inflammation and
normal cell death. These effects may be counteracted
through the use of altered fractionation schedules, immu-
notherapy or a radioprotector such as amifostine (1, 18, 19).
Here, we extend our previously published study on out-
of-field dose effects and bystander effects in a model of
prostate cancer (8), to explore the responses of normal and
radiosensitive lymphocyte cell lines and primary human
blood cells as a surrogate for lymphocytes within the tumor
microenvironment. The goal of this study was to determine
if both out-of-field dose and bystander factor could affect
DNA damage, growth and gene expression in lymphocyte
cell lines, and elucidate these effects in the tumor
microenvironment and surrounding normal tissue.
MATERIALS AND METHODS
Blood Samples and Cell Lines
Blood samples (20 ml) were taken by venipuncture from healthy
donors. Ethical approval was obtained from the Dublin Institute of
Technology (DIT) Research Ethics Committee (15–32), and all donors
gave informed consent. Blood was plated 2 h prior to irradiation, at a
final volume of 5 ml per T25 flask (Sarstedt, Numbrecht, Germany),
comprising 2 ml blood and 3 ml RPMI 1640 medium (Sigma Aldrich,
Co Wexford, Ireland) supplemented with 12.5% fetal bovine serum
(FBS) and 1% L-glutamine (Gibco, Waltham, MA). At 1 and 24 h
postirradiation, peripheral blood mononuclear cells (PBMC) were
isolated from whole blood by density centrifugation and fixed for
DNA damage analysis.
In this study, Jurkat T cells, THP-1 monocytic cells, and C1,
AT3ABR, AT2Bi and AT3Bi lymphoblast cell lines were used. The
C1 (derived from a healthy donor) and AT3ABR [derived from an
ataxia telangiectasia (A-T) patient] cell lines were kindly gifted by the
Queensland Institute of Medical Research (Herston, Australia) (20).
The AT2Bi and AT3Bi cell lines were kindly gifted from the College
of Medical and Dental Sciences, University of Birmingham
(Birmingham, UK). Both AT2Bi and AT3Bi are derived from A-T
patients and have a total absence of the ataxia telangiectasia-mutated
(ATM) protein, which is recruited to DNA double-strand breaks to
initiate repair (21, 22). Ataxia telangiectasia is a syndrome arising
from a mutation in the ATM gene, resulting in an absence of this
protein (23). Among the clinical manifestations of this deficiency is
sensitivity to ionizing radiation (24). Therefore, A-T cell lines were
used as a surrogate for radiosensitive primary human blood cells.
Culture of Cell Lines
Jurkat T cells, THP-1 monocytic cells, and C1, AT3ABR, AT2Bi
and AT3Bi lymphoblast cells were cultured in RPMI 1640 media
supplemented with 12.5% FBS and 1% L-glutamine, at 378C and 5%
CO2. Cells were seeded 18 h prior to irradiation, at 2 3 10
4 cells
(growth curves), or 2 3 105/ml (all other assays), at a final volume of 5
ml per T25 flask (Sarstedt).
Irradiation Conditions
Cell irradiation conditions mimicked those previously reported by
our group using a 6-MV photon beam produced by an Elekta Precise
Linac (Elekta Oncology Systems, Crawley, UK) and a specially
designed phantom permitting simultaneous irradiation of cells
positioned to receive an in-field and out-of-field dose as described
in detail by Shields et al. (8). Briefly, cells placed in-field (target cells)
were exposed to 2 Gy. Flasks irradiated in the out-of-field position
received an average dose of 10.8 6 4.2 cGy, as measured using
Gafchromice film. Sham-irradiated flasks served as a control.
Isolation of Conditioned Media
Irradiated cell conditioned media (ICCM) was isolated from directly
irradiated cells as a source of bystander factors. At 1 h postirradiation,
sham- and in-field-exposed cells were centrifuged at 400g for 5 min.
The supernatant was isolated and filtered through a 0.2-lm filter
(Corningt Inc., Corning, NY). Bystander factors were added to sham-
irradiated or out-of-field cells for c-H2AX, growth curve or gene
expression analysis 1 h postirradiation. The timepoint of 1 h was
chosen in accordance with previously published studies of the
bystander effect (8, 25).
Gamma-H2AX Analysis
DNA damage was determined using c-H2AX analysis and
measured by flow cytometry. Cells were fixed at 1 and 24 h
postirradiation or the addition of ICCM using 2% paraformaldehyde
and stored in 70% ethanol at –208C. To stain, cells were
permeabilized, followed by blocking with a 4% FBS solution in
phosphate buffered saline (PBS) for 30 min. A primary antibody
solution [anti-phospho-histone H2A.X (Ser139), clone JBW301,
1:500; Merck Millipore, Darmstadt, Germany] was added and
incubated overnight at 48C, followed by 1 h incubation with the
secondary antibody [F(ab’)- goat anti-mouse IgG (HþL), Alexa
Fluort 488, 1:200; Thermo Fishere, Carlsbad, CA) at room
temperature. Cells were counterstained with 1% propidium iodide
solution and analyzed on an Accurie C6 flow cytometer (BD, Oxford,
UK). The mean fluorescence of 10,000 cells was calculated using the
Accuri C6 Sampler software, with cells stained only with the
secondary antibody serving as a negative control for each sample.
Cell Growth Curves
Growth assays were performed after irradiation or the addition of
bystander factors. Cells were seeded, irradiated and counted after 5–7
days. For bystander experiments, sham-irradiated and out-of-field cells
were resuspended in ICCM at 1 h postirradiation. Cells were counted
using a Coultert cell counter (Beckman Coultert, Maryfort, Ireland),
total cell numbers calculated and analyzed with reference to sham-
irradiated controls.
Gene Expression
Gene expression was evaluated using real-time PCR (RT-PCR).
RNA was extracted from cells using the phenol-chloroform method
and concentration measured using the NanoDrop (Maestrogen, Las
Vegas, NV). CDNA was synthesized using the Qscript cDNA kit
(Quantabio, Beverly, MA), according to manufacturer’s instructions.
Primers for cytokines known to play a role in the bystander response,
IL-1, IL-6, TNFa and TNGb, were designed (Table 1) and synthesized
(Sigma-Aldrich, Wexford, Ireland) and reactions were performed in
duplicate in 96-well plates (Applied Biosystemst, Carlsbad, CA).
Each reaction was composed of 10 ll SYBR Green (Kapa Biosystems,
London, UK), 1 ll each of forward and reverse primers, 6 ll PCR
grade water and 2 ll cDNA. Non-template controls replaced cDNA
with 2 ,ll PCR-grade water. Reactions were run on AB 7500 fast
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PCR cycler (Applied Biosystems), with 45 cycles programmed per
plate.
Statistics
Statistical analysis and graphing were performed using Prism, demo
version 6 (GraphPad Software Inc., La Jolla, CA). Normal distribution
of data was determined using the Kolmogorov-Smirnov and Shapiro
Wilk tests. Statistical significance was calculated using paired or
unpaired t tests as appropriate.
RESULTS
Out-of-Field Radiation Dose Induces c-H2AX Expression in
Radiosensitive Cells
The effect of out-of-field radiation dose on DNA damage
was investigated in T cells, monocytes, and normal and
radiosensitive lymphocyte cell lines. Measurement of DNA
damage by c-H2AX staining revealed no significant change
in mean fluorescence intensity (MFI) in Jurkat (at 1 and 24
h) and THP-1 cells (1 h) after irradiation (Fig. 1A and B).
However, a significant increase in c-H2AX was observed in
the radiosensitive AT3ABR cells at 1 h postirradiation (Fig.
1D), which was not observed in non-radiosensitive C1 cells
(Fig. 1C). Both cell lines showed a modest increase in c-
H2AX expression at 24 h, although these changes were not
significant and showed high inter-experimental variation.
Out-of-Field Radiation Dose Decreases Growth of
Radiosensitive Cells
Growth curve analysis was performed to explore the
effects of out-of-field dose on cell proliferation. Growth of
Jurkat, THP-1 and C1 cell lines were unaffected by out-of-
field dose. However, there was a significant decrease in the
proliferation of the radiosensitive AT3ABR cells (Fig. 2A–
D).
Bystander Factors Isolated from Cells of Different
Radiosensitivities can Alter Radiation Responses
To model intercellular crosstalk through production of
soluble mediators, ICCM was added to cells that received
sham-irradiation and out-of-field dose. DNA damage and
growth responses were measured in Jurkat and THP-1 cells,
however, addition of ICCM did not alter these responses
with ICCM alone or in combination with out-of-field
placement, consistent with the findings shown in Figs. 1 and
2 (data not shown).
The potency of ICCM generated from cell lines with
varying radiosensitivities was subsequently investigated. As
shown in Fig. 3A, increased DNA damage was observed
after treatment of sham and irradiated C1 cells with C1
ICCM, although this was not significant. The addition of
radiosensitive AT3ABR sham-irradiated media and ICCM
to irradiated C1 cells, shown in the hashed bars, resulted in
a further onefold increase in c-H2AX expression compared
to cells treated with C1 ICCM. However, as shown in Fig.
3B, addition of C1 ICCM to AT3ABR cells did not alter
their response.
Figure 3C and D shows the percentage cell growth after
treatment compared to control levels (sham-irradiated cells
treated with sham media). While C1 cells were unaffected
by addition of C1 ICCM, there was a relative decrease in
cell growth on addition of AT3ABR ICCM, although this
was not significant. A significant decrease in growth of
AT3ABR cells after out-of-field dose was observed, as
shown in Fig. 2D. Treatment of irradiated AT3ABR cells
with sham C1 media also resulted in a significant increase in
AT3ABR cell growth compared to addition of sham
AT3ABR media. This indicates that soluble mediators from
cells of different radiosensitivities can affect cell responses
to radiation, regardless of whether the media was isolated
from sham or irradiated cells.
Out-of-Field Radiation Dose and Addition of Bystander
Factors Alters Cytokine Expression
We next investigated whether out-of-field dose and
radiosensitive ICCM could modulate cytokine gene expres-
sion in responding cells. Two further radiosensitive cell
lines (AT2Bi and AT3Bi) were used to determine if results
with AT3ABR cells were applicable to other radiosensitive
cell lines. Cytokines implicated in the bystander response,
IL-1, IL-6, TNFa and TGFb, were measured in all cell lines.
C1 cells showed a varied pattern of expression (Fig. 4).
An adaptive response was observed for IL-1; no expression
was detected in out-of-field cells, while a 10-fold increase
was observed in expression sham cells with ICCM.
However, this difference was not significant due to inter-
replicate variation (Fig. 4A). No increase in expression of
IL-6 was seen with either radiation or ICCM treatment (Fig.
4B). A reciprocal effect was seen with TNFa and TGFb,
TABLE 1
Forward and Reverse Primer Sequences for Housekeeping Gene Actin, and for Target Genes IL-1, IL-6, TNFa and
TGFb
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where the highest TNFa expression was measured in out-of-
field cells but not with ICCM treatment, with the opposite
effect observed for TGFb expression (Fig. 4C and D).
The cytokine expression of the radiosensitive cell lines
(AT3ABR, AT2Bi and AT3Bi) differed from the C1 cell
line, but also from each other. The response of AT3ABR
was similar to that of C1 in IL-1 and IL-6 expression, but
showed no TNFa expression after an out-of-field dose
alone. An adaptive effect was observed in the AT3ABR
cells for TGFb expression, with a 680-fold increase in the
sham AT3ABR cells treated with ICCM, which was
reduced to a 200-fold increase when the cells received an
out-of-field dose and ICCM. However, this did not reach
statistical significance due to high variation. Similar patterns
in IL-6 expression were observed in both A-T cell lines,
with no expression in out-of-field cells, a modest increase in
sham cells with ICCM, which was further increased when
out-of-field cells and ICCM were combined. No expression
of TNFa was observed in either A-T cell lines. Expression
of TGFb in AT2Bi cells mirrored that of AT3ABR cells,
however, the only increase observed in AT3Bi cells was in
the cells positioned out-of-field and treated with ICCM
(175-fold compared to sham) (Figs. 4A–5D).
Treatment of Normal Responding Cells with ICCM from
Cells of Different Radiosensitivities Varies Their Cytokine
Gene Expression Pattern
As shown in Fig. 3, treatment with radiosensitive
AT3ABR ICCM increased DNA damage and reduced the
growth of C1 cells. To determine if this effect was also
observed in cytokine gene expression patterns, C1 cells
were treated with radiosensitive ICCM from all three A-T
cell lines (Fig. 5).
The expression pattern of IL-1 was not altered by the
addition of radiosensitive ICCM, with an adaptive effect
observed, as shown in Fig. 4. However, there was an
increase in IL-6 expression in sham cells treated with
radiosensitive ICCM, the most marked observed with
AT3ABR ICCM with a threefold increase over cells treated
with C1 ICCM (Fig. 5A). There were no changes in IL-6
FIG. 1. Out-of-field dose increases c-H2AX expression in radiosensitive cells. Jurkat, THP-1, C1 and
AT3ABR cells (panels A–D, respectively) were plated in T25 flasks 18 h prior to irradiation (1 3 106, 5 ml).
Cells were exposed in the out-of-field position (1 cm from target field). Nonirradiated (sham) cells served as
controls. Cells were fixed 1 h postirradiation and stained forc-H2AX expression. Stained cells were analyzed
using flow cytometry, with 10,000 events acquired per sample. Mean fluorescence intensity 6 SEM is shown. n
¼ 5 independent experiments. Significance was calculated using paired t test, **P , 0.01.
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expression, except for a large increase in expression after
addition of AT3Bi ICCM to irradiated C1 cells (Fig. 5B).
There was no increase in TNFa expression above that seen
with out-of-field dose alone (Fig. 5C). Addition of AT2Bi
and AT3Bi ICCM increased TGFb expression in C1 cells,
although this occurred whether the cells had been irradiated
or not. This effect was also found in C1 cells treated with
C1 ICCM, where an increase in TGFb expression was
observed after treatment with ICCM regardless of exposure
(Fig. 5D).
A correlation analysis was performed to determine if there
was a relationship between c-H2AX expression and
cytokine expression in C1 cells. All treatment parameters
were included. Figure 6 show an inverse correlation
between normalized c-H2AX expression and TNFa expres-
sion; where one mediator increased, the other decreased.
Out-of-Field Radiation Dose Increases DNA Damage in
Primary Human Peripheral Blood Mononuclear Cells
We next sought to determine if out-of-field dose induced
DNA damage in primary human blood cells. As shown in
Fig. 7, there was a significant increase in c-H2AX
expression after out-of-field dose at 1 h, which had
decreased to baseline levels after 24 h. These data indicate
that the out-of-field dose can induce the DNA damage
response in primary human blood cells.
DISCUSSION
As radiotherapy techniques advance, continued explora-
tion of normal tissue effects is important to reduce radiation-
induced early and late toxicities. In the current work, we
used a clinically relevant experimental setup, whereby the
target cells are exposed to 2 Gy, and the out-of-field cells
are positioned 1 cm from the target to model normal tissue
effects. Using this model, we have previously shown that
out-of-field dose induced DNA damage in normal prostate
cells (8). Here, we extended these findings to normal and
radiosensitive lymphocyte cell lines as a surrogate for
tumor-adjacent immune cells. Furthermore, we treated out-
of-field cells with ICCM to examine the effects of bystander
factors produced by irradiated tumor cells during radiation
treatment.
The most significant effect of out-of-field dose was
observed in radiosensitive cells, with an increase in c-
FIG. 2. Out-of-field dose decreases growth of radiosensitive cells. Jurkat, THP-1, C1 and AT3ABR cells
(panels A–D, respectively) were plated in T25 flasks 18 h prior to irradiation (5 3 104, 5 ml). Cells were exposed
in the out-of-field position (1 cm from target field). Nonirradiated (sham) cells served as controls. Cells were
counted at day 5 postirradiation using a cell counter and the irradiated flasks were expressed as a percentage of
the sham flasks. Pooled data from 3–5 independent experiments are shown, mean 6 SEM, and significance
calculated using paired t test on raw data, *P , 0.05.
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H2AX at 1 h postirradiation, and a decrease in cell growth
at day 5 postirradiation (Figs. 1D and 2D). Although the
dose received by out-of-field cells is in the hyper-
radiosensitivity range (maximum dose of 0.2 Gy), no other
cell line tested showed a significant increase in DNA
damage or decrease in growth. This agrees with Park et al.
who showed that direct irradiation with doses of 0.05 and
0.1 Gy had no significant effect on the viability of THP-1 or
Jurkat cells (26).
A significant increase in expression of c-H2AX in healthy
control PBMC was also seen after the out-of-field dose (Fig.
7). We observed that the early increase in c-H2AX was
reduced to baseline after 24 h; however, it is unknown
whether this was due to DNA repair or apoptosis. These
findings agree with a previously published study by Siva et
al., who measured c-H2AX foci in PBMC of non-small
lung cancer patients before, during and after fractionated
radiation therapy (27). They observed increased c-H2AX
foci at 1 h postirradiation, which returned to baseline levels
at 24 h. The PBMC represented the normal cells in the
target volume in these patients; however, they also
measured DNA damage in eyebrow hair follicles as a
model for out-of-field tissues and the abscopal effect, which
is the clinical manifestation of the bystander effect. They
demonstrated a significant increase in c-H2AX foci up to 4
weeks postirradiation, showing evidence of sustained DNA
damage initiated through circulating cytokines and chemo-
kines (27).
When normally responding C1 cells were treated with
ICCM from radiosensitive cells, an increase in DNA
damage in cells that received an out-of-field dose was
observed (Fig. 3A). We also saw a modest decrease in cell
proliferation, but this was limited to sham cells treated with
ICCM. This could indicate an adaptive response to the
priming dose of radiation, which is specific to ICCM
derived from AT3ABR cells, given that this also occurred
FIG. 3. Radiosensitive ICCM alters normal cell responses to out-of-field dose and autologous ICCM. C1 and
AT3ABR cells were plated for c-H2AX and growth assays as before, with ICCM generated as described in Fig.
3. ICCM from each cell line was added to their own cell line (open bars) and to the opposite cell line (hashed
bars), both sham-irradiated and out-of-field dose. After 1 h, cells were isolated for c-H2AX (panels A and B) and
growth assays (panels C and D). Data from three independent experiments are shown, mean 6 SEM with
significance calculated using paired t tests, *P , 0.05.
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with irradiated AT3ABR cells and AT3ABR ICCM (Fig.
3D). It is unclear whether this effect of radiosensitive cell
ICCM is due to a factor that is not present in normal cell
ICCM, or a change in concentration of a factor present in
both normal and radiosensitive ICCM. It was previously
shown that the bystander factors generated from cells that
were deficient in DNA repair mechanisms were more toxic
(28–30). Nagasawa et al. found that when wild-type CHO
cells were treated with alpha particles, for every nucleus that
was traversed, 3–4 nearby cells were at risk of mutations.
However, up to 50 nearby cells were at risk of mutation
after a single nuclei traversal in DNA repair-deficient cells.
Furthermore, analysis of the nature of these mutations
revealed that approximately 80% of the mutations in the
DNA repair-deficient cells were deletions, compared to 50%
in the wild-type cells (28). Mothersill et al. demonstrated
that repair-deficient cells produced more cell death in both
autologous and reporter cell lines than repair-proficient
cells, and postulated that repair-deficient cells induce
increased death as a response to increased levels of DNA
damage (30). An effect was also seen in C1 and AT3ABR
responder cells on addition of ICCM from sham-irradiated
cells (Fig. 3). Sham ICCM from AT3ABR cells increased
DNA damage in irradiated C1 cells, while sham C1 ICCM
increased the proliferation of irradiated AT3ABR cells. The
reasons for this are unclear; however, it has previously been
shown that ATM-deficient cells have a higher level of basal
DNA damage and chromosomal instability, which requires
more time to resolve compared to normally responding cells
(31, 32). It is possible that sham-irradiated AT3ABR cells
underwent some basal damage, which took longer to resolve
and thus, there was some level of mediators still present in
the ICCM after the 1-h timepoint of isolation. Sham C1
ICCM may have contained some mediators that mitigated
the decrease in proliferation of the irradiated AT3ABR cells,
however, further investigation is necessary to determine
what these factors are. It was shown by Furlong et al. that
apoptotic pathways differ between those induced by direct
irradiation, and through the bystander effect. The majority
of apoptosis-related genes were expressed at 24 h after
ICCM transfer (33). These data may explain our observa-
tions in the AT3ABR cell line, and the differential effects
seen at 1 h (DNA damage) and day 5 (cell proliferation).
However, further studies are needed to establish which cell
death pathways are induced in our model.
Further insight into this model may be reflected in the
differences in genes critical for the DNA damage response.
The radiosensitive cell models used in this study were
FIG. 4. Normal and radiosensitive cells show different patterns of cytokine gene expression after out-of-field
dose and ICCM. C1, AT3ABR, AT2Bi and AT3Bi cells were plated for out-of-field dose and ICCM generation
18 h prior to irradiation (1 3 106, 5 ml/T25 flask). At 1 h postirradiation or addition of ICCM, cells were
resuspended in TRI Reagent for RNA extraction. Panels A–D: Expression of IL-1, IL-6, TNFa and TGFb,
respectively, was measured by RT-PCR (SYBR Green, ABI 7500 cycler) and fold changes calculated with
respect to sham values. Data from 4–5 independent experiments are shown, mean 6 SEM.
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isolated from A-T patients and thus, are defective or
deficient in ATM. The DNA damage response is initiated
by members of the phosphatidylinositol 3-kinase-related
kinase (PIKK) family, including ATM, ataxia telangiecta-
sia-mutated and Rad3-related (ATR), and DNA-dependent
protein kinase catalytic subunit (DNA-PKcs). Research over
the past decade has shown that these DNA damage sensors
play different roles in directly irradiated cells and cells
damaged through the bystander response (34–36). While
ATM and ATR are both employed in the DNA damage
response in directly irradiated cells, ATR predominates in
bystander cells, with ATM activated downstream and
dependent on ATR (34, 35). Studies using ATM-deficient
cell lines showed that while c-H2AX was significantly
increased in bystander cells, there was no decrease in their
survival, although this was observed if the cells were
directly irradiated (34). It was also shown that ATR could
substitute for ATM in ATM-deficient cells in repairing
endogenous damage, but not that induced by ionizing
radiation (37). Data in this study showed increased DNA
damage and decreased survival in ATM-deficient out-of-
field cells, and an ability of these cells to produce bystander
responses in normally responding cells without showing a
bystander response themselves (Figs. 1–3). However,
ICCM from all three ATM-deficient cell lines could
differentially modulate cytokine gene expression in an
autologous manner and in normally responding cells (Figs.
4 and 5). As briefly discussed in the Materials and Methods,
AT3ABR, AT2Bi and AT3Bi do not have functional ATM;
however, their expression of ATR and other related proteins
is expected to be complete. Further investigation is required
to determine what DNA damage response pathways are
involved in the response to out-of-field dose and production
or response to bystander factors.
The tumor microenvironment and its surrounding healthy
tissue consist of an interplay between the tumor cells and
their associated immune, endothelial and stromal cells,
blood vessels, mediators of oxidative stress, chemokines
and cytokines. Because of this heterogeneity, some cells
may be more radiosensitive than others, due to their
phenotype or their position within the cell cycle. Further-
more, early and late radiotherapy-related toxicities, such as
FIG. 5. Radiosensitive ICCM alters cytokine gene expression of normal cells. C1 cells were plated for out-of-
field dose, with C1, AT3ABR, AT2Bi and AT3Bi cells plated for ICCM generation as described here. ICCM
from all cell lines was added to sham-irradiated and out-of-field C1 cells at 1 h postirradiation. After incubation
for 1 h, cells were isolated for RNA extraction and analysis as previously described. Panels A–D: Shown are fold
changes in expression of IL-1, IL-6, TNFa and TGFb, respectively, with respect to sham C1 cells. Data are
representative of 4–5 independent experiments, mean 6 SEM.
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late radiation-induced fibrosis, have a strong immune
component. This is initiated with an early release of
cytokines such as TNFa, IL-1 and IL-6, followed by TGFb
[reviewed in (5)]. We therefore investigated cytokine gene
expression in normally responding cells and whether this
response was altered by radiosensitive ICCM. We observed
a highly variable gene expression pattern in both normal and
radiosensitive cell lines, and in normal cells after ICCM
treatment. Both pro- and anti-inflammatory genes were
expressed after out-of-field dose, and both were increased
by treatment with radiosensitive ICCM, although this was
not observed in every cell-ICCM combination across all
cytokines measured.
It is known that low doses of radiation (,1 Gy) stimulate
an anti-inflammatory milieu (38). This results in an increase
in TGFb production and a decrease in IL-1b and TNFa
(39). This anti-inflammatory environment favors the M2
phenotype of macrophages within the tumor and surround-
ing area, which further perpetuates this suppressive and pro-
tumor environment (40). We observed an increase in IL-1
gene expression in radiosensitive cells compared to normal
cells, and a large increase in normal cells that had been
treated with radiosensitive ICCM. However, these levels
were reduced to baseline on combining out-of-field dose
and ICCM, indicating that low-dose exposure has an anti-
inflammatory effect. A similar effect was previously shown
using a murine model of prostate cancer, where peritoneal
macrophages from radiosensitive mice produced decreased
amounts of IL-1b after 0.5 and 0.7 Gy irradiation (41). We
also observed low expression of TNFa in all radiosensitive
cells and cells treated with radiosensitive ICCM. In fact,
TNFa was the only gene to significantly correlate with c-
H2AX levels in these cells, showing an inverse relationship:
the lower the expression of TNFa, the higher the c-H2AX
expression (Fig. 6). It is known that at higher concentra-
tions, TNFa has anti-tumor effects, although at lower
concentrations, it is pro-tumor and promotes cell survival
(42). We observed an increased expression of TGFb in both
radiosensitive cells and in normal cells treated with
radiosensitive ICCM. Wunderlich et al. recently reported
that 0.1, 0.3 and 0.5 Gy X-ray irradiation to the peritoneal
macrophages from radiosensitive (Balb/c) mice resulted in a
significant increase in TGFb and reduced IL-1b, indicating
an immunosuppressive environment after low-dose irradi-
ation (43). The data presented here show a wide-ranging
response to both bystander factors from cells of varying
radiosensitivities and out-of-field doses. Although further
work is required to determine if these responses are also
FIG. 6. Inverse correlation observed between TNFa and c-H2AX
expression in normal responding cells. C1 cells were plated for the
out-of-field dose as before and ICCM from all cell lines was added to
sham-irradiated and out-of-field C1 cells at 1 h postirradiation. After
incubation for 1 h, cells were isolated for RNA extraction and
analysis. Shown is a correlation analysis of TNFa and c-H2AX MFI
of all C1 cells, treated with ICCM or untreated. *P ¼ 0.0341, R2 ¼
0.4488, Pearson ¼ –0.6699.
FIG. 7. Out-of-field dose induces DNA damage in primary human
blood mononuclear cells. Whole blood was obtained by venipuncture
and plated in T25 flasks on the day of irradiation (2 ml blood, 3 ml-
RPMI/flask). Flasks received an out-of-field dose, with target field
exposed to 2 Gy. Nonirradiated flasks served as sham cells. At 1 and
24 h postirradiation, PBMC were isolated by density centrifugation
and fixed for c-H2AX analysis. Shown are data from six donors, mean
MFI 6 SEM. Significance was calculated using Wilcoxon rank test,
**P , 0.01.
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observed at the protein level, it could be hypothesized that
radiosensitive individuals may favor a more immunosup-
pressive tumor microenvironment, which could affect anti-
tumor responses.
CONCLUSION
This study shows that out-of-field dose induces early
DNA damage in radiosensitive cell lines and primary blood
cells and reduces cell proliferation over five days. This has
implications for damage of normal cells during radiation
therapy, particularly in radiosensitive individuals. Addition-
ally, bystander factors produced by directly irradiated cells
may upregulate cytokine gene expression in a pro- or anti-
inflammatory manner, which may affect neighboring
nonirradiated cells. These responses could be further altered
by the combination of conditioned media and out-of-field
dose, potentially skewing the response towards a more
immunosuppressive and pro-tumor milieu. Given these and
other findings, the mechanism of the complicated interplay
of these factors within the tumor microenvironment
warrants further study, with a view toward increasing the
efficacy of radiation therapy and decreasing early and late
toxicities for all patients.
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